LENZ Therapeutics Inc. (LENZ)
NASDAQ: LENZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.68 +1.66%
LENZ stock chart
Technical analysisKey statistics
All statistics- Market cap
- $113.74M
- EPS (TTM)
- -$4.13
- Dividend yield
- None
- Ex-dividend date
- Mar 22, 2024
- 52-week range
- 3.46 – 49.25
- Day range
- 3.59 – 3.72
- Volume / Avg
- 515.17K / 838.15K
- Beta
- —
- Shares outstanding
- 31.42M
- Next earnings
- Nov 4, 2026
52-week range
LENZ stock today
On Oct 7, LENZ ended the session at $3.62, shedding $0.17 (4.49%), versus the S&P 500's 0.22% decline. Shares are 92.6% below their 52-week high of $49.25, set on Oct 8, 2025 and 4.8% above the 52-week low of $3.46, near the bottom of the past year's range. LENZ is down 77.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 92.3%.
LENZ Therapeutics has posted a net loss over the last twelve months (EPS of -$4.13), so its P/E ratio is not meaningful. LENZ Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About LENZ Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-1.01
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $7.21
- Ex-dividend date
- Mar 22, 2024
LENZ Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TNYATenaya Therapeutics Inc. | 0.5334 | -2.40% | $119.60M | vs LENZ |
| ENGNenGene Therapeutics Inc. | 1.75 | -3.06% | $116.94M | vs LENZ |
| HUMAHumacyte Inc. | 0.4723 | -1.19% | $131.20M | vs LENZ |
| BDTXBlack Diamond Therapeutics Inc. | 1.83 | +1.67% | $104.86M | vs LENZ |
| ARMPArmata Pharmaceuticals Inc. | 3.81 | -1.04% | $141.66M | vs LENZ |
| AVXLAnavex Life Sciences Corp. | 1.53 | -4.38% | $141.83M | vs LENZ |
| OTLKOutlook Therapeutics Inc. | 0.59 | +3.15% | $143.63M | vs LENZ |
| ATRAAtara Biotherapeutics Inc. | 9.37 | -3.90% | $94.05M | vs LENZ |
Indexes, lists and sector
Appears in lists
LENZ Therapeutics stock FAQ
What is LENZ Therapeutics's stock price today?
LENZ last traded at $3.62 as of Oct 7, 4:00 PM EDT, down 4.49% on the day. Prices are delayed at least 15 minutes.
Does LENZ Therapeutics pay a dividend?
Yes. LENZ Therapeutics pays $0.00 per share annually. The most recent dividend of $7.21 had an ex-dividend date of Mar 22, 2024.
When is LENZ Therapeutics's next earnings date?
LENZ Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-1.01.
Has LENZ ever split its stock?
Yes. The most recent LENZ stock split was a 1-for-7 split on Mar 22, 2024.
What is the LENZ 52-week high?
The 52-week high for LENZ is $49.25 and the 52-week low is $3.46. The stock is currently 92.6% below its high.